Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors Journal Article


Authors: Panageas, K. S.; Reiner, A. S.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; Ashby, L. S.; Cairncross, J. G.; Urgoiti, G. B.; Wen, P. Y.; Ligon, K. L.; Schiff, D.; Robins, H. I.; Rocque, B. G.; Chamberlain, M. C.; Mason, W. P.; Weaver, S. A.; Green, R. M.; Kamar, F. G.; Abrey, L. E.; Deangelis, L. M.; Jhanwar, S. C.; Rosenblum, M. K.; Lassman, A. B.
Article Title: Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors
Abstract: BACKGROUND: Anaplastic oligodendroglial tumors are rare, and median survival varies widely. Analysis of 1p19q deletion is performed commonly and is an important prognostic factor. However, age and other clinical variables also carry prognostic value, and it is unclear how to incorporate them into clinical decision making or to combine them for prognostication. METHODS: We compiled a retrospective database of 1013 patients with newly diagnosed anaplastic oligodendrogliomas or oligoastrocytomas and performed a recursive partitioning analysis to generate independent prognostic classes among 587 patients with informative 1p19q status. Variables included for survival classification were age (continuous), history of prior low-grade glioma, 1p19q deletion status, histology (presence or absence of an astrocytic component), tumor lobe, tumor hemisphere, gender, extent of resection, postresection treatment, and performance status at diagnosis. RESULTS: Recursive partitioning analysis identified 5 prognostic groups based on hazard similarity: class I (age <60 y, 1p19q codeleted), class II (age <43 y, not codeleted), class III (age 43-59 y, not codeleted, frontal lobe tumor or age ≥60 y, codeleted), class IV (age 43-59 y, not codeleted, not frontal lobe tumor or age 60-69 y, not codeleted), and class V (age ≥70 y, not codeleted). Survival differences were highly significant (P < .0001), with medians ranging from 9.3 years (95% CI: 8.4-16.0) for class I to 0.6 years (95% CI: 0.5-0.9) for class V. CONCLUSIONS: These 5 distinct classification groups were defined using prognostic factors typically obtained during routine management of patients with anaplastic oligodendroglial tumors. Validation in a prospective clinical trial may better differentiate patients with respect to treatment outcome. © The Author(s) 2014. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Keywords: adolescent; adult; aged; aged, 80 and over; middle aged; survival rate; retrospective studies; young adult; genetics; mortality; cancer staging; follow up; brain neoplasms; follow-up studies; neoplasm staging; chromosome 1; classification; retrospective study; oligodendroglioma; chromosome deletion; chromosomes, human, pair 1; decision trees; recursive partitioning analysis; anaplastic oligoastrocytoma; decision tree; anaplastic; very elderly; humans; prognosis; human; male; female; 1p19q deletion
Journal Title: Neuro-Oncology
Volume: 16
Issue: 11
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2014-11-01
Start Page: 1541
End Page: 1546
Language: English
DOI: 10.1093/neuonc/nou083
PUBMED: 24997140
PROVIDER: scopus
PMCID: PMC4201067
DOI/URL:
Notes: Export Date: 2 July 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anne S Reiner
    251 Reiner
  2. Marc Rosenblum
    424 Rosenblum
  3. Fabio M Iwamoto
    36 Iwamoto
  4. Andrew Lassman
    111 Lassman
  5. Lauren E Abrey
    278 Abrey
  6. Katherine S Panageas
    519 Panageas
  7. Suresh C Jhanwar
    293 Jhanwar